Redeye views favorably on yet another positive study, this time regarding the skin barrier and atopic dermatitis (AD). The study performed by the Swiss Institute of Allergy and Asthma Research (SIAF) shows excellent results by using Nevisense to characterize the skin barrier in atopic dermatitis.